Ann: Investor Webinar, page-87

My view is this is positive. Hopper is greasing the wheels with instos. The timing ahead of imminent herrvax and pd1 results is a goodwill offering. If you have some big influential funds offering you money with which you get more certainty / leverage plus you can buy future favour, why not! They were at pains to state these were health science instos. You would expect such specialist fund would be connected into the hospital and research community and know on which doors they need to be knocking. As always, time will tell.

I liked they threw in some free oppies on the SPP. At least an attempt to look after the retailers who have supported them so loyally to date. Didn't rate Leslies performance. Thought her answers were too short and peremptory. Still a massive Leslie fan but felt she was uncomfortable with the scenario in which she found herself.